Article thumbnail

Alpha-santalol, a chemopreventive agent against skin cancer, causes G2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells

By Xiaoying Zhang, Wei Chen, Ruth Guillermo, Gudiseva Chandrasekher, Radhey S Kaushik, Alan Young, Hesham Fahmy and Chandradhar Dwivedi
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). Alberts DS: Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res
  2. (2003). Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer
  3. (2003). Cancer prevention – the potential for diet to modulate molecular signalling. Trends Mol Med
  4. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. JC l i nP a t h o l1999,
  5. (2006). Chemopreventive effects of alpha-santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice. Carcinogenesis
  6. (2005). Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer. Pathology
  7. (2000). Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis
  8. (2003). DP: Chemopreventive effects of alphasantalol on skin tumor development in CD-1 and SENCAR mice. Cancer Epidemiol Biomarkers Prev
  9. (2003). Draetta GF: Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep
  10. (2007). Dwivedi C: Chemoprevention by alphasantalol on UVB radiation-induced skin tumor development in mice. Anticancer Res
  11. (2008). Dwivedi C: Effects of alpha-santalol on proapoptotic caspases and p53 expression in UVB irradiated mouse skin. Anticancer Res
  12. (2006). Geley S: Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells.
  13. (2004). HM: Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms. Carcinogenesis
  14. (2008). Hsieh TC: Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by lipoic acid: role in cancer prevention and therapy.
  15. (1994). Kastan MB: Cell cycle control and cancer. Science
  16. (2008). Katiyar SK: Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci
  17. (2002). KG: Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database. Carcinogenesis
  18. (2004). Kite GC: Evaluation of the quality of sandalwood essential oils by gas chromatography-mass spectrometry. J Chromatogr A
  19. (2004). Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst)
  20. (1998). Manson MM: Suppression of tumour development by substances derived from the diet–mechanisms and clinical implications.
  21. (2003). Meyskens FL: Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea. Recent Results Cancer Res
  22. (2000). Pietenpol JA: p53 regulation of G (2) checkpoint is retinoblastoma protein dependent. Mol Cell Biol
  23. (1995). Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev
  24. (2009). Sarcophine-diol, a Chemopreventive Agent of Skin Cancer, Inhibits Cell Growth and Induces Apoptosis through Extrinsic Pathway in Human Epidermoid Carcinoma A431 Cells. Transl Oncol
  25. (2006). Scolyer RA: The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology
  26. (2005). Skin cancer chemopreventive agent, alpha-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release. Carcinogenesis
  27. (2004). Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-Sspecific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res
  28. (2002). The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol Cancer Ther
  29. (2005). The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11’-dideoxyverticillin-induced G2/M arrest. FEBS Lett
  30. (2009). Yagura T: Heterocyclic organobismuth(III) compound targets tubulin to induce G2/M arrest in HeLa cells.
  31. (2008). YC: Diallyl disulfide induces reversible G2/M phase arrest on a p53-independent mechanism in human colon cancer HCT-116 cells. Oncol Rep
  32. (2009). YH: Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines. Cancer